Healthpeak Properties, Inc. (New York Stock Exchange:DOC)
| Market Cap | 13.27B+1.0% |
| Revenue (ttm) | 2.95B+5.5% |
| Net Income | 253.72M+53.8% |
| EPS | 0.35+50.7% |
| Shares Out | 689.53M |
| PE Ratio | 55.00 |
| Forward PE | 87.23 |
| Dividend | $1.22(6.34%) |
| Ex-Dividend Date | Dec 18, 2026 |
| Volume | 6,178,049 |
| Open | 19.45 |
| Previous Close | 19.34 |
| Day's Range | 19.11 - 19.54 |
| 52-Week Range | 15.70 - 22.95 |
| Beta | 0.99 |
| Analysts | Hold |
| Price Target | 22.00(+14.29%) |
| Earnings Date | Nov 2, 2026 |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About DOC
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
$DOC stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of DOC by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 9, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 8, 2026 |
Recently reported changes in DOC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DOC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DOC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
DOC Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Adjusted NOI - outpatient medical and lab | $340.62M | 24.77% |
| Outpatient medical | $310.67M | 22.59% |
| Senior housing | $216.46M | 15.74% |
| Lab | $216.11M | 15.71% |
| NOI - outpatient medical and lab | $206.59M | 15.02% |
| Gain (loss) upon change of control, net | $46.27M | 3.36% |
| Plus: Adjustments to NOI | $20.57M | 1.50% |
| Gain (loss) on sales of real estate, net | $9.99M | 0.73% |
| Other non-reportable revenues | $6.57M | 0.48% |
| Impairments and loan loss reserves, net | $1.48M | 0.11% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New DOC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DOC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DOC
| ETF | Est. Holding Size |
|---|---|
| VNQVanguard Real Estate ETF | $521.35M |
| VTIVanguard Morningstar Total Stock Market ETF | $438.23M |
| VOOVanguard S&P 500 ETF | $361.62M |
| VBVanguard Morningstar Small-Cap ETF | $309.95M |
| VBRVanguard Morningstar Small-Cap Value ETF | $201.72M |
| RSPInvesco S&P 500 Equal Weight ETF | $185.36M |
Estimated from each fund’s disclosed top holdings × AUM
DOC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from DOC’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.